3626
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(843,295) Views
Editor in Chief Professor Garry Walsh
Editorial ||FREE PAPER||Garry Walsh
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Frieder Bauss and Ralph C Schimmer
Oxybutynin: an overview of the available formulations
Rebecca J McCrery, Rodney A Appell
Ciclesonide for the treatment of asthma
Ronald Dahl
Anti-hepatitis C virus therapy in liver transplanted patients
Antonino Picciotto
Etoricoxib for arthritis and pain management
Peter Brooks, Paul Kubler
Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, Daryl J Hoban
Differences between the bisphosphonates for the prevention and treatment of osteoporosis
Andrew Grey, Ian R Reid
Renal cell carcinoma and the use of sorafenib
James MG Larkin, Tim Eisen
Percutaneous dermal drug delivery for local pain control
Sujatha Tadicherla, Brian Berman
Transdermal buprenorphine in the management of persistent pain – safety aspects
Rudolf Likar
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
